TF Capital
TF Capital is a venture capital firm based in Shanghai, China, founded in November 2013. The firm specializes in early-stage and growth capital investments primarily in the life sciences sector. Its focus areas include biotechnology, therapeutics, pharmaceuticals, drug delivery, medical devices, and medical services. TF Capital aims to support preclinical and early clinical-stage companies, contributing to innovation and development in the life sciences industry.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Cayman Islands
Xgene Pharmaceutical
Series B in 2018
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Xgene Pharmaceutical
Series A in 2017
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.